Abstract:Yongyan Zhou, Haojie Xie, Yi Zhao, Jinwei Zhang, Yanfei Li, Ranran Duan, Yaobing Yao, Yanjie Jia Department of Neurology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, People's Republic of China Correspondence: Yanjie Jia Department of Neurology, The First Affiliated Hospital of Zhengzhou University, Erqi District, Zhengzhou City, Henan Province, People's Republic of China Tel +861 351 380 2916 Email Purpose: To investigate the relationship between the neutrophil-to-lymphocyte ratio (NLR) and the severity of neurological impairment at disease onset in patients with a first episode of neuromyelitis optica spectrum disorder (NMOSD). Patients and Methods: This retrospective study included 259 patients with newly diagnosed NMOSD who were hospitalized at our institution between January 2013 and January 2020 (NMOSD group) and 169 healthy control subjects who underwent a physical examination at our hospital during the same period (control group). The clinical data collected included general information, past medical history, biochemical test results, imaging findings, NLR, AQP-4 antibody status, and initial Expanded Disability Status Scale score. A logistic regression model was used to analyze NLR as an independent risk factor for the severity of neurological impairment at disease onset in the NMOSD group. Receiver-operating characteristic curve analysis was used to evaluate the ability of the NLR to predict the severity of neurological impairment at disease onset in the NMOSD group and to determine its critical value. Results: The NLR was significantly higher in the NMOSD group than in the control group ( P < 0.001). In the NMOSD group, neurological impairment at disease onset was more severe in those with a high NLR than in those with a low NLR ( P < 0.001). At onset of disease, patients with severe neurological impairment had a more significant increase in NLR than those with mild-to-moderate neurological impairment ( P < 0.001). Both univariate (OR 1.180, 95% CI 1.046– 1.331, P =0.007) and multivariate (OR 1.146, 95% CI 1.003– 1.308, P =0.044) logistic regression analyses showed that the NLR was positively correlated with the severity of neurological impairment at onset of disease in the NMOSD group. The area under the receiver-operating characteristic curve was 0.687. Conclusion: The NLR is an independent risk factor for the severity of neurological impairment at disease onset in patients with a first episode of NMOSD. Keywords: neuromyelitis optica spectrum disorder, neutrophil-to-lymphocyte ratio, first episode, severity, Expanded Disability Status Scale score Neuromyelitis optica spectrum disorder (NMOSD) is a primary inflammatory demyelinating disease of the central nervous system (CNS) that mainly involves the optic nerve and spinal cord and characterized by antiaquaporin-4 (AQP4) antibody-mediated autoimmune astrocytopathy. 1 Recent worldwide epidemiological surveys showed differences in the regional and ethnic prevalence of NMOSD and a higher prevalence in Africans and non-whites. 2 , 3 Most patients with NMOSD have a relapsing-remitting course, with an increase in the number of relapses, a decrease in the recovery rate, an increase in the degree of disability, and, eventually, severe visual or motor impairment with progression of the disease. 4 Diagnosis of NMOSD is based mainly on clinical manifestations, AQP4 antibody status in serum or cerebrospinal fluid (CSF), and manifestations in the spinal cord or optic nerve seen on magnetic resonance imaging (MRI). In recent years, many researchers have focused on biological indicators of the severity of neurological impairment in patients with NMOSD. However, little progress has been made in terms of identification of cost-effective, easily accessible, and reliable biological indicators that would assist in early detection of patients with NMOSD to improve the prognosis. The neutrophil-to-lymphocyte ratio (NLR) is a novel inflammatory index that has been used to predict the prognosis of non-small cell lung cancer, squamous cell carcinoma of the lung, colorectal cancer, liver cancer, esophageal and gastric cancer, kidney cancer, bladder cancer, melanoma and other malignant tumors, as well as cerebral hemorrhage, cerebral infarction, and cardiovascular disease. 5–15 The NLR has also been associated with the activity of multiple sclerosis, systemic lupus erythematosus, Sjogren's syndrome, Behçet's disease, and other autoimmune diseases. <a href="#cit -Abstract Truncated-

Neutrophil-to-Lymphocyte Ratio Is Independently Associated With Severe Psychopathology in Schizophrenia and Is Changed by Antipsychotic Administration: A Large-Scale Cross-Sectional Retrospective Study

The neutrophil-to-Lymphocyte ratio is associated with clinical symptoms in first-episode medication-naïve patients with schizophrenia

The neutrophil-lymphocyte ratio in first-episode medication-naïve patients with schizophrenia: A 12-week longitudinal follow-up study

Neutrophil/lymphocyte ratio and cognitive performances in first-episode patients with schizophrenia and healthy controls

Neutrophil–Lymphocyte Ratio Values in Schizophrenia: A Comparison between Oral and Long-Acting Antipsychotic Therapies

Neutrophil/lymphocyte ratio is increased in the acute phase of schizophrenia and regardless the use and types of antipsychotic drugs

Neutrophil-to-Lymphocyte Ratio in Adult Community-Acquired Pneumonia Patients Correlates with Unfavorable Clinical Outcomes

Neutrophil/lymphocyte, Platelet/lymphocyte and Monocyte/lymphocyte Ratios in Schizophrenia

Changes in Inflammatory Biomarkers in Patients with Schizophrenia: A 3-Year Retrospective Study

Altered neutrophil-to-lymphocyte ratio in patients with non-affective first episode psychosis and its relationship with symptom severity and cognitive impairment

Association between the neutrophil-to-lymphocyte ratio and psoriasis: a cross-sectional study of the National Health and Nutrition Examination Survey 2011-2014

The relationship between neutrophil-lymphocyte, platelet-lymphocyte ratio, monocyte- lymphocyte ratio and cognitive function in schizophrenia

The Associations of Neutrophil-Lymphocyte, Platelet-Lymphocyte, Monocyte-Lymphocyte Ratios and Immune-Inflammation Index with Negative Symptoms in Patients with Schizophrenia

Hematological and inflammatory markers in Han Chinese patients with drug-free schizophrenia: relationship with symptom severity

Association between neutrophil-to-lymphocyte ratio and specific depressive symptoms: an analysis of a population-based cross-sectional survey

Association of the neutrophil to lymphocyte ratio and white blood cell count with response to pharmacotherapy in unipolar psychotic depression: An exploratory analysis

Association between the neutrophil-to-lymphocyte ratio and cognitive impairment: a meta-analysis of observational studies

Inflammatory Markers of Hemogram Parameters As Predictive Factors for Disease Severity in Anti-N-methyl-d-aspartate Receptor Encephalitis.

Neutrophil-lymphocyte Ratio as a Predictor of Delirium in Older Hospitalized Patients: A Prospective Cohort Study

Association between neutrophil to lymphocyte ratio and inflammatory biomarkers in patients with a first episode of psychosis

Neutrophil-to-Lymphocyte Ratio on Admission is an Independent Risk Factor for the Severity of Neurological Impairment at Disease Onset in Patients with a First Episode of Neuromyelitis Optica Spectrum Disorder